Clinical trial
An Open Label Evaluation of Intralesional Injection of Sodium Thiosulfate in the Treatment of Cutaneous or Tendon Calcinosis in Connective Tissue Disease
NCT06672822 is registered in ClinicalTrials.gov with Robyn T. Domsic, MD, MPH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Evaluation of Intralesional Injection of Sodium Thiosulfate in the Treatment of Cutaneous or Tendon Calcinosis in Connective Tissue Disease
- Lead sponsor
- Robyn T. Domsic, MD, MPH
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- March 17, 2025
- Completion date
- May 1, 2029
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
calcinosis, dermatomyositis, mixed connective tissue disease (mctd), systemic sclerosis (ssc)